Clinical Investigator Administrative Actions - Disqualification: Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors
Information
Type
Guidance
Regulated products
Biologics, Drugs, Medical Devices
Topics
Good Clinical Practice (GCP)
Published
December 1, 2022
Last updated
January 17, 2023
Description
This document provides guidance for Institutional Review Boards, Clinical Investigators, and Sponsors on disqualification actions in clinical investigations.
Tags
Organization
Country / Region
United States
License
Other (Public Domain)